Financial statements Przedsiębiorstwo Produkcji Farmaceutyczno-Kosmetycznej Profarm
Balance sheet data of PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNO-KOSMETYCZNEJ PROFARM
Year
|
2019
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 8 361 611,98 | 8 652 816,99 | 7 428 877,66 | 7 239 543,63 |
A. Fixed assets | 3 894 303,19 | 4 411 731,71 | 3 721 528,16 | 3 343 250,01 |
B. Current assets | 4 467 308,79 | 4 241 085,28 | 3 707 349,50 | 3 896 293,62 |
C. Share capital contributions (basic funds) | - | - | - | - |
D. Own shares (stocks) | - | - | - | - |
Total liabilities | 8 361 611,98 | 8 652 816,99 | 7 428 877,66 | 7 239 543,63 |
A. Equity | 4 893 554,83 | 5 560 972,83 | 5 570 130,06 | 5 723 303,25 |
B. Liabilities and provisions for liabilities | 3 468 057,15 | 3 091 844,16 | 1 858 747,60 | 1 516 240,38 |
I. Long-term liabilities | 246 323,06 | 37 694,89 | 15 301,02 | 725 524,72 |
II. Short-term liabilities | 1 837 847,63 | 2 749 198,24 | 1 616 348,31 | 641 469,55 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.